Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of FLUAD versus control influenza vaccines in unprimed healthy children
2007-003786-41Phase 3Terminated
- Sponsor
- Novartis
- Start
- Jul 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of Fluzone Trivalent in influenza (2 arms), sponsored by Novartis. Primary endpoint: Strain-specific hemagglutination inhibition immunogenicity. Started Jul 2007; status: terminated.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2007-003786-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003786-41.